We use cookies to give you the best possible experience on our website.

The challenges we face

Companies, especially SMEs, can face significant challenges to introduce their new and innovative products into the NHS. The complexity of public procurement, patient safety and a risk averse culture across multiple organisations can be daunting. The Innovation Nexus aims to provide a single source of resource that can help companies, particularly SMEs, understand the steps that need to be taken to support their business planning and engage with the NHS more easily, thus progressing the adoption of their innovation at pace and with fewer unanticipated obstacles.

a fully funded intensive support programme for life science SMEs working in Greater Manchester

How can the Innovation Nexus help me?

Speak directly to a GM AHSN advisor with NHS expertise

Help with navigating NHS procurement

Information about funding and investment

Help with setting up a trial of your innovation

Information on science parks and office locations

Connect you with relevant organisations

 

Free industry support from NHS experts

If you are a business with an innovative product or service that you believe has the potential to benefit the healthcare market, the Innovation Nexus can give you access a network of specialist advice and support.

Subscribe to our mailing list

* indicates required

Asset Publisher Asset Publisher

Back

New funding opportunities for healthcare companies in Greater Manchester

Greater Manchester Academic Health Science Network (GM AHSN) has announced it will re-open its three funding streams to provide support to innovative healthcare practices that address the health and social care needs of the city region. 

The funding streams will be formally launched during a live webinar on Friday 16th June, which will broadcast from 12pm. The webinar aims to provide attendees with an overview of the three streams of funding that are available as well as information about the types of needs GM AHSN is looking to address. Please register for the webinar here

GM AHSNs Innovation Funds were established to support the introduction and adoption of needs-led, evidence-based innovations by the NHS within the GM footprint. This will improve the health of GM citizens by funding the development of products and solutions that are not currently being used by the NHS in the region. Additionally, this will support economic development and wealth creation through the growth of local businesses and job.

 

 

Information about the funds 

The Ignite Fund is designed to support early stage development of innovative solutions to identify unmet need within GM AHSN footprint. The themes for Ignite Fund applications are Patient Safety and Mental Health. The Ignite Fund has a total of up to £75,000 available this year.  Applicants may apply for funding up to a maximum value of £25,000 (inc. VAT). 

The Energise Fund is specifically designed to support proof of concept or prototyping projects. These innovations should be focused on GM AHSN priority areas. The Energise Fund has a total of up to £125,000 available this year.  Applicants may apply for funding up to a maximum value of £25,000 (inc. VAT.). 

The Momentum Fund is specifically designed to provide funding support to help SMEs or NHS organisations with innovative products or services accelerate progress to significant milestones. These innovations should be focused on GM AHSN priority areas. The Momentum Fund has a total of up to £200,000 available this year.  Applicants may apply for funding up to a maximum value of £25,000 (inc. VAT). 

Click here for more information about the funds.